From Singapore’s banking results to Elon Musk’s trillion-dollar payday - markets are buzzing with big money moves.
Singapore’s three big banks - DBS, OCBC, and UOB - are showing their hand this earnings season, revealing who’s playing defense and who’s cashing in.
Michelle Martin breaks down the numbers behind OCBC’s steady profits and DBS’s record highs, plus UOB’s caution.
Across the Pacific, Trump’s deal with Eli Lilly and Novo Nordisk could reshape the obesity drug market.
And Tesla’s US$1 trillion pay plan for Elon Musk? It’s the governance story investors can’t ignore.
Plus, a quick game of Up or Down featuring Genting Singapore, SingTel, CapitaLand Investment, and SGX.

Market View: AI Spending Jitters Shake Wall Street as Allianz Bets on Singapore
14:53

Money and Me: Finding Alpha Beyond the Blue Chips: 4 Singapore Small-Cap Stocks in Focus
22:02

Market View: SpaceX, Grab and Sea Arrive on SGX as AI Powers Wall Street Higher
15:00